Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Envista stock
Learn how to easily invest in Envista stock.
Envista is a medical instruments & supplies business based in the US. Envista shares (NVST) are listed on the NYSE and all prices are listed in US Dollars. Envista employs 12,700 staff and has a trailing 12-month revenue of around $2.6 billion.
How to buy Envista stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NVST. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Envista stock price (NYSE: NVST)Use our graph to track the performance of NVST stocks over time.
Envista shares at a glance
|Latest market close||$31.89|
|52-week range||$31.67 - $43.94|
|50-day moving average||$37.07|
|200-day moving average||$36.28|
|Wall St. target price||$44.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.16|
Buy Envista stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Envista stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Envista price performance over time
Historical closes compared with the close of $31.89 from 2023-05-31
|1 week (2023-05-25)||-3.22%|
|1 month (2023-05-01)||-16.97%|
|3 months (2023-03-01)||-17.40%|
|6 months (2022-12-01)||-9.40%|
|1 year (2022-06-01)||-24.09%|
|2 years (2021-06-01)||-25.70%|
|3 years (2020-06-01)||48.67%|
|5 years (2018-05-28)||N/A|
Is Envista stock undervalued or overvalued?
Valuing Envista stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Envista's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Envista's P/E ratio
Envista's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Envista shares trade at around 29x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Envista's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $488.7 million.
The EBITDA is a measure of a Envista's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.6 billion|
|Operating margin TTM||13.48%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||3.29%|
|Return on equity TTM||5.09%|
|Market capitalisation||$5.4 billion|
TTM: trailing 12 months
Envista share dividends
We're not expecting Envista to pay a dividend over the next 12 months.
Envista share price volatility
Over the last 12 months, Envista's shares have ranged in value from as little as $31.67 up to $43.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Envista's is 1.4216. This would suggest that Envista's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals.
Envista in the news
Envista Holdings' (NYSE:NVST) three-year total shareholder returns outpace the underlying earnings growth
Envista Announces Participation in Stifel 2023 Jaws & Paws Conference
Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
Frequently asked questionsWhat percentage of Envista is owned by insiders or institutions?
Currently 0.339% of Envista shares are held by insiders and 115.619% by institutions. How many people work for Envista?
Latest data suggests 12,700 work at Envista. When does the fiscal year end for Envista?
Envista's fiscal year ends in December. Where is Envista based?
Envista's address is: Building E, Brea, CA, United States, 92821-6208 What is Envista's ISIN number?
Envista's international securities identification number is: US29415F1049 What is Envista's CUSIP number?
Envista's Committee on Uniform Securities Identification Procedures number is: 29415F104
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert